UK Dermatology Clinical Trials Network
search site
Home
About the UK DCTN
Trials in Development
Trials at Red Stage
Trials at Amber Stage
Trials at Green Stage
Trials at Peer Review
Ongoing Trials
Completed Trials
Submit a Trial Idea
UK DCTN Awards
Trial Development Support
Meetings & Training
Clinical Research Updates
Newsletters & Publications
Patients' Section
Members' Area
Vacancies
Contact Us
Trials at Green Stage

                                                             

Lead investigator:

Jerry Marsden, Birmingham.

Interventions: 

This is an open label, non-randomised phase II study.  Patients will undergo 12 weeks of treatment with topical imiquimod.  They will be seen at 2, 4 and 8 weeks for possible dose adjustment.  All patients will progress to re-mapping, biopsy and complete surgical excision.  The entire specimen will be sectioned and examined histologically, and pathological complete, partial or no response will be determined.

Outcomes:

Primary outcome measure is to establish the histological complete response rate of imiquimod for treating lentigo maligna.

Justification for the trial:

Topical treatment for lentigo maligna would avoid many of the limitations of surgery and radiotherapy.  This study could provide valuable information about the effectiveness of imiquimod.

If you would like further details about this study, or would like to help with recruitment, please contact Jo Chalmers.

This study is to be funded by the NIHR Research for Patient Benefit programme.


                                                   

Lead investigator: Jemima Mellerio, London
Interventions:  Trimethoprim, dosage and comparitor to be decided
Outcomes: To be decided
Justification for the trial:

Initial discussions and prioritisation of trial ideas with leading clinicians in EB have led to this study being identified as the most achievable and relevant at the current time.

If you would like further details about this study, or would like to help with recruitment, please contact Jo Chalmers.

Funding has not yet been secured for this trial.


For details of how to get involved with Peer Review of any proposals, go to Trials for Peer Review.

Patch Study
Stop-Gap Pilot
Join Now
Blister Study
Centre of Evidence Based Dermatology
site designed by ludwood interactive